Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
7.73
-0.20 (-2.52%)
At close: Apr 28, 2026, 4:00 PM EDT
7.67
-0.06 (-0.78%)
After-hours: Apr 28, 2026, 4:00 PM EDT
Adicet Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | - | - | - | 24.99 | 9.73 | |
| Revenue Growth (YoY) | - | - | - | 156.83% | -45.65% | |
| Gross Profit | - | - | - | 24.99 | 9.73 | |
| Selling, General & Admin | 22.99 | 28.29 | 26.53 | 26.3 | 22.22 | |
| Research & Development | 99.13 | 99.32 | 106.04 | 71.25 | 47.75 | |
| Operating Expenses | 122.11 | 127.62 | 132.58 | 97.54 | 69.97 | |
| Operating Income | -122.11 | -127.62 | -132.58 | -72.55 | -60.24 | |
| Interest Expense | -0.04 | -0 | -0.03 | -0.08 | -0.18 | |
| Interest & Investment Income | 5.78 | 10.71 | 9.98 | 3.76 | 0.09 | |
| Other Non Operating Income (Expenses) | -0.43 | -0.22 | -0.57 | -0.92 | -0.61 | |
| EBT Excluding Unusual Items | -116.8 | -117.12 | -123.2 | -69.79 | -60.93 | |
| Impairment of Goodwill | - | - | -19.46 | - | - | |
| Asset Writedown | - | - | - | - | -1.19 | |
| Pretax Income | -116.8 | -117.12 | -142.66 | -69.79 | -62.12 | |
| Income Tax Expense | - | - | - | - | -0.13 | |
| Net Income | -116.8 | -117.12 | -142.66 | -69.79 | -62 | |
| Net Income to Common | -116.8 | -117.12 | -142.66 | -69.79 | -62 | |
| Shares Outstanding (Basic) | 7 | 5 | 3 | 3 | 2 | |
| Shares Outstanding (Diluted) | 7 | 5 | 3 | 3 | 2 | |
| Shares Change (YoY) | 25.49% | 104.14% | 4.78% | 32.72% | 322.85% | |
| EPS (Basic) | -16.95 | -21.33 | -53.03 | -27.18 | -32.05 | |
| EPS (Diluted) | -16.95 | -21.33 | -53.03 | -27.18 | -32.05 | |
| Free Cash Flow | -96.98 | -93.5 | -98.18 | -61.55 | -64.1 | |
| Free Cash Flow Per Share | -14.07 | -17.02 | -36.50 | -23.97 | -33.13 | |
| Gross Margin | - | - | - | 100.00% | 100.00% | |
| Operating Margin | - | - | - | -290.32% | -619.15% | |
| Profit Margin | - | - | - | -279.27% | -637.19% | |
| Free Cash Flow Margin | - | - | - | -246.29% | -658.77% | |
| EBITDA | -115.73 | -121.15 | -126.48 | -69.98 | -58.71 | |
| EBITDA Margin | - | - | - | -280.02% | - | |
| D&A For EBITDA | 6.38 | 6.47 | 6.1 | 2.58 | 1.54 | |
| EBIT | -122.11 | -127.62 | -132.58 | -72.55 | -60.24 | |
| EBIT Margin | - | - | - | -290.32% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.